Literature DB >> 18689392

Development of a standard reference material for vitamin D in serum.

Karen W Phinney1.   

Abstract

The most widely used indicator of vitamin D status is the measurement of 25-hydroxyvitamin D [25(OH)D] in either serum or plasma. Several studies have reported discrepancies between the results of assays used to measure 25(OH)D, however, which calls into question the ability of 25(OH)D assays to reflect accurately the vitamin D status of individuals. The National Institute of Standards and Technology has been working with the National Institutes of Health's Office of Dietary Supplements to develop a standard reference material for circulating vitamin D analysis. This standard reference material will provide a material with stable, well-defined levels of the analytes of interest. Investigators will be able to use the standard reference material to validate new analytic methods as they are developed and to assign values to in-house quality-control materials.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18689392     DOI: 10.1093/ajcn/88.2.511S

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  52 in total

1.  Seasonal variation in 25-hydroxyvitamin D concentrations in the cardiovascular health study.

Authors:  Abigail B Shoben; Bryan Kestenbaum; Gregory Levin; Andrew N Hoofnagle; Bruce M Psaty; David S Siscovick; Ian H de Boer
Journal:  Am J Epidemiol       Date:  2011-11-23       Impact factor: 4.897

2.  Standardizing 25-hydroxyvitamin D values from the Canadian Health Measures Survey.

Authors:  Kurtis Sarafin; Ramón Durazo-Arvizu; Lu Tian; Karen W Phinney; Susan Tai; Johanna E Camara; Joyce Merkel; Evan Green; Christopher T Sempos; Stephen P J Brooks
Journal:  Am J Clin Nutr       Date:  2015-09-30       Impact factor: 7.045

3.  Impact of vitamin D3 dietary supplement matrix on clinical response.

Authors:  Michael L Traub; John S Finnell; Anup Bhandiwad; Erica Oberg; Lena Suhaila; Ryan Bradley
Journal:  J Clin Endocrinol Metab       Date:  2014-03-31       Impact factor: 5.958

4.  Low 25-hydroxyvitamin D levels in people with a solid tumor cancer diagnosis: the tip of the iceberg?

Authors:  Katherine Hauser; Declan Walsh; Shiva Shrotriya; Matthew Karafa
Journal:  Support Care Cancer       Date:  2014-02-28       Impact factor: 3.603

5.  Serum 25-hydroxyvitamin-D and nonalcoholic fatty liver disease: Does race/ethnicity matter? Findings from the MESA cohort.

Authors:  Samar R El Khoudary; Saad Samargandy; Irfan Zeb; Temitope Foster; Ian H de Boer; Dong Li; Matthew J Budoff
Journal:  Nutr Metab Cardiovasc Dis       Date:  2019-09-10       Impact factor: 4.222

6.  25-Hydroxyvitamin D Concentration and Sleep Duration and Continuity: Multi-Ethnic Study of Atherosclerosis.

Authors:  Suzanne M Bertisch; Stefan Sillau; Ian H de Boer; Moyses Szklo; Susan Redline
Journal:  Sleep       Date:  2015-08-01       Impact factor: 5.849

7.  Mass spectrometric immunoassay for quantitative determination of transthyretin and its variants.

Authors:  Olgica Trenchevska; Elena Kamcheva; Dobrin Nedelkov
Journal:  Proteomics       Date:  2011-08-09       Impact factor: 3.984

8.  Differential effects of phosphate binders on vitamin D metabolism in chronic kidney disease.

Authors:  Charles Ginsberg; Leila R Zelnick; Geoffrey A Block; Glenn M Chertow; Michel Chonchol; Andrew Hoofnagle; Bryan Kestenbaum; Ian H de Boer
Journal:  Nephrol Dial Transplant       Date:  2020-04-01       Impact factor: 5.992

Review 9.  Vitamin D and metabolites measurement by tandem mass spectrometry.

Authors:  Johannes M W van den Ouweland; Michael Vogeser; Silvia Bächer
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

10.  Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Michael C Sachs; Abigail Shoben; Gregory P Levin; Cassy Robinson-Cohen; Andrew N Hoofnagle; Nancy Swords-Jenny; Joachim H Ix; Matthew Budoff; Pamela L Lutsey; David S Siscovick; Bryan Kestenbaum; Ian H de Boer
Journal:  Am J Clin Nutr       Date:  2013-04-24       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.